Wolfarth S, Ossowska K
Department of Neuro-Psychopharmacology, Polish Academy of Sciences, Kraków, Poland.
Pol J Pharmacol. 1995 May-Jun;47(3):207-18.
The aim of the review is a brief description of the present status of research and perspectives in the field of multiple dopamine receptors, as well as of the importance of new discoveries for the treatment of schizophrenic psychoses and Parkinson's disease. Since the discovery of D1 and D2 dopamine receptors in the seventhies, evidence has accumulated for the existence of some new dopamine receptors. Among them the D3, D4 and D5 receptors, as well as their isoforms have been cloned. Molecular biology and pharmacology of these receptors have been exhaustively studied in recent years. These studies have prompted a number of hypotheses which open new perspectives for investigation into pathophysiology and therapy of schizophrenia and Parkinson's disease.
本综述旨在简要描述多多巴胺受体领域的研究现状与前景,以及新发现对治疗精神分裂症和帕金森病的重要性。自20世纪70年代发现D1和D2多巴胺受体以来,越来越多的证据表明存在一些新的多巴胺受体。其中,D3、D4和D5受体及其亚型已被克隆。近年来,对这些受体的分子生物学和药理学进行了详尽研究。这些研究催生了一些假说,为精神分裂症和帕金森病的病理生理学及治疗研究开辟了新的前景。